Fora Capital, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Fora Capital, LLC

$1.19 Billion
Q1 2024

A detailed history of Fora Capital, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fora Capital, LLC holds 7,324 shares of REGN stock, worth $7.65 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

7,324

Holding current value

$7.65 Million

% of portfolio

0.59%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$902.69 - $993.35 $6.61 Million - $7.28 Million	7,324 New	7,324 $7.05 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $5.71 Million - $6.96 Million	8,244 New	8,244 $6.78 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $6.47 Million - $7.86 Million	9,504 New	9,504 $7.81 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $4.13 Million - $5.22 Million	7,204 New	7,204 $4.96 Million
Q2 2022 Aug 11, 2022	SELL	$548.35 - $738.84 $2.88 Million - $3.88 Million	-5,250 Closed	0 $0

Q1 2022 May 12, 2022	BUY	$595.12 - $698.43 $3.12 Million - $3.67 Million	5,250 New	5,250 $3.64 Million
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $2.72 Million - $3.36 Million	-5,006 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $749,683 - $889,333	1,306 Added 35.3%	5,006 $3.03 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $1.75 Million - $2.07 Million	3,700 New	3,700 $2.07 Billion
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $125,531 - $154,044	-281 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $134,402 - $170,842	281 New	281 $135,000
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $1.77 Million - $2.61 Million	-5,278 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $1.45 Million - $1.99 Million	5,278 New	5,278 $1.98 Million

Others Institutions Holding REGN

# of Institutions

1,426

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.

Account